These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 8101394)

  • 21. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.
    Aalto S; Brück A; Laine M; Någren K; Rinne JO
    J Neurosci; 2005 Mar; 25(10):2471-7. PubMed ID: 15758155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration.
    Morgan D; Grant KA; Gage HD; Mach RH; Kaplan JR; Prioleau O; Nader SH; Buchheimer N; Ehrenkaufer RL; Nader MA
    Nat Neurosci; 2002 Feb; 5(2):169-74. PubMed ID: 11802171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose.
    London ED; Cascella NG; Wong DF; Phillips RL; Dannals RF; Links JM; Herning R; Grayson R; Jaffe JH; Wagner HN
    Arch Gen Psychiatry; 1990 Jun; 47(6):567-74. PubMed ID: 2350209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.
    Schlaug G; Hefter H; Nebeling B; Engelbrecht V; Weiss P; Stöcklin G; Seitz RJ
    J Neurol; 1994 Oct; 241(10):577-84. PubMed ID: 7836960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
    Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
    Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain glucose metabolism and dopamine D2 receptor analysis in a patient with hemiparkinsonism-hemiatrophy syndrome.
    Przedborski S; Goldman S; Levivier M; Giladi N; Bidaut LM; Hildebrand J; Stanus E; Labar D; Luxen A
    Mov Disord; 1993 Jul; 8(3):391-5. PubMed ID: 8341311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin 5-HT2 receptor availability in chronic cocaine abusers.
    Wang GJ; Volkow ND; Logan J; Fowler JS; Schlyer D; MacGregor RR; Hitzemann RJ; Gjedde A; Wolf AP
    Life Sci; 1995 Mar; 56(16):PL299-303. PubMed ID: 8614247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal.
    Wang GJ; Volkow ND; Fowler JS; Logan J; Abumrad NN; Hitzemann RJ; Pappas NS; Pascani K
    Neuropsychopharmacology; 1997 Feb; 16(2):174-82. PubMed ID: 9015800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review.
    Wang GJ; Volkow ND; Thanos PK; Fowler JS
    J Addict Dis; 2004; 23(3):39-53. PubMed ID: 15256343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; Hitzemann R; Chen AD; Dewey SL; Pappas N
    Nature; 1997 Apr; 386(6627):830-3. PubMed ID: 9126741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions.
    Volkow ND; Wang GJ; Fowler JS; Franceschi D; Thanos PK; Wong C; Gatley SJ; Ding YS; Molina P; Schlyer D; Alexoff D; Hitzemann R; Pappas N
    Life Sci; 2000 Feb; 66(12):PL161-7. PubMed ID: 10737368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
    Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
    Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic involvement during mental fatigue in health and cocaine addiction.
    Moeller SJ; Tomasi D; Honorio J; Volkow ND; Goldstein RZ
    Transl Psychiatry; 2012 Oct; 2(10):e176. PubMed ID: 23092980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography.
    Alavi A; Reivich M; Ferris S; Christman D; Fowler J; MacGregor R; Farkas T; Greenberg J; Dann R; Wolf A
    Exp Brain Res; 1982; Suppl 5():187-95. PubMed ID: 6983979
    [No Abstract]   [Full Text] [Related]  

  • 38. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy.
    Goffinet AM; De Volder AG; Gillain C; Rectem D; Bol A; Michel C; Cogneau M; Labar D; Laterre C
    Ann Neurol; 1989 Feb; 25(2):131-9. PubMed ID: 2784043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.
    Leenders KL; Frackowiak RS; Quinn N; Marsden CD
    Mov Disord; 1986; 1(1):69-77. PubMed ID: 2973559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.
    Ben-Shahar O; Keeley P; Cook M; Brake W; Joyce M; Nyffeler M; Heston R; Ettenberg A
    Brain Res; 2007 Feb; 1131(1):220-8. PubMed ID: 17161392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.